Showing results (431-440 of 823) with videos related to

Sort By:
Pageof 83
The Journal of Clinical Endocrinology and Metabolism|January 1, 1995
Adrenocorticotropin hyperresponse to the corticotropin-releasing hormone-mediated stimulus of naloxone in patients with myotonic dystrophyJ E Grice, R V Jackson, G I Hockings, et al.
Alimentary Pharmacology & Therapeutics|March 7, 2018
Systematic review: adrenal insufficiency secondary to swallowed topical corticosteroids in eosinophilic oesophagitisH Philpott, M K Dougherty, C C Reed, et al.
Clinical and Experimental Pharmacology & Physiology|July 23, 1998
Pituitary-adrenal responses to combined oral D-fenfluramine and intravenous naloxone in humansJ E Grice, D J Torpy, G I Hockings, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1996
MHC class II expression--a new tool to assess dignity in adrenocortical tumoursC Marx, G W Wolkersdörfer, J W Brown, et al.
Journal of Endocrinological Investigation|November 1, 1996
Expression of interleukin-1 in human pheochromocytomaS R Bornstein, M Ehrhart-Bornstein, J González-Hernández, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|November 10, 2007
Low-density lipoproteins induce the renin-angiotensin system and their receptors in human endothelial cellsR A Catar, G Müller, J Heidler, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1996
Functional aspects of the effect of prolactin (PRL) on adrenal steroidogenesis and distribution of the PRL receptor in the human adrenal glandA Glasow, M Breidert, A Haidan, et al.
Atherosclerosis. Supplements|January 30, 2013
Differences in the atherogenic risk of patients treated by lipoprotein apheresis according to their lipid patternM von Dryander, S Fischer, J Passauer, et al.
Endocrine Research|November 1, 1996
Evaluation of apoptotic parameters in normal and neoplastic human adrenalG W Wolkersdörfer, C Marx, J W Brown, et al.
Pageof 83